Stock listing
NASDAQ:DMK DMK Pharmaceuticals Corporation Stock
Follow DMK Pharmaceuticals Corporation into a list and get an email when it puts out news.
Delisted NASDAQ:DMK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DMK
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Where DMK Pharmaceuticals Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DMK · This page · Delisted | NASDAQ | United States | USD |
| OTC:DMKPQ · Delisted | OTC | United States | USD |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Tina Susan Nova Other companies: Aurinia Pharmaceuticals Inc (Director · Since at least May 15, 2025); Azenta, Inc. (Director · Since at least Feb 3, 2023); Exagen Inc. (Director · Since at least Sep 18, 2019); CapForce Inc. (Director · Apr 24, 2017 – Sep 2, 2019 · Past); Veracyte, Inc. (President, CLIA U.S. · Nov 12, 2015 – Mar 3, 2022 · Past); NanoString Technologies Inc (Director · Apr 29, 2014 – Apr 29, 2014 · Past); Genoptix Inc (President and CEO, Director · Oct 29, 2007 – Mar 7, 2011 · Past); Cypress Bioscience Inc (Director · Apr 26, 2007 – Jan 4, 2010 · Past); Arena Pharmaceuticals Inc (Director · Jul 28, 2006 – Mar 11, 2022 · Past) | Director · Feb 10, 2011 – Oct 16, 2013 · Past |
| Craig Johnson Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); La Jolla Pharmaceutical Co (Director · Oct 14, 2013 – Aug 22, 2022 · Past); PURE Bioscience (Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past); Ardea Biosciences Inc (Director · Jan 3, 2011 – Jun 19, 2012 · Past) | Director · Feb 10, 2011 – Oct 16, 2013 · Past |
| Howard C Birndorf Other companies: Nanogen Inc (Executive Chairman and CEO, Director · Jun 13, 2007 – Apr 2, 2008 · Past) | Director · Aug 26, 2019 – Nov 14, 2022 · Past |
| Ebrahim Versi | CEO, Director · May 25, 2023 – Sep 15, 2023 · Past |
| John W Dorbin Jr | General Counsel · Oct 23, 2023 – Oct 23, 2023 · Past |
| Meera J Desai | Director · Oct 1, 2021 – May 25, 2023 · Past |
| Robert B Rothermel | Director · Dec 20, 2006 – May 24, 2019 · Past |
| Robert O Hopkins | Chief Financial Officer · Sep 29, 2020 – Feb 21, 2021 · Past |
| Seth Cohen | CFO · Oct 16, 2023 – Oct 16, 2023 · Past |
| Thomas Moll | VP of Research · Aug 2, 2011 – Feb 21, 2018 · Past |
Log in to ask 6ix AI your own questions about DMK Pharmaceuticals Corporation.